journal article·2018-04

Synthesis of water dispersible boron core silica shell (B@SiO2) nanoparticles

Nathan I. Walton, Zhe Gao, Yulia Eygeris, Hamidreza Ghandehari, Ilya Zharov

Journal of Nanoparticle Research· Volume 20· Issue 4
Publisher page

Abstract

Water dispersible boron nanoparticles have great potential as materials for boron neutron capture therapy of cancer and magnetic resonance imaging, if they are prepared on a large scale with uniform size and shape and hydrophilic modifiable surface. We report the first method to prepare spherical, monodisperse, water dispersible boron core silica shell nanoparticles (B@SiO2 NPs) suitable for aforementioned biomedical applications. In this method, 40 nm elemental boron nanoparticles, easily prepared by mechanical milling and carrying 10-undecenoic acid surface ligands, are hydrosilylated using triethoxysilane, followed by base-catalyzed hydrolysis of tetraethoxysilane, which forms a 10-nm silica shell around the boron core. This simple two-step process converts irregularly shaped hydrophobic boron particles into the spherically shaped uniform nanoparticles. The B@SiO2 NPs are dispersible in water and the silica shell surface can be modified with primary amines that allow for the attachment of a fluorophore and, potentially, of targeting moieties.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Boron Compounds in Chemistry · Boron and Carbon Nanomaterials Research · Chemical Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. Bai Y, Peng J, Hu Y et al (2009) Effect of aminoaromatic acids as additives on the activity and selectivity of the platinum-catalyzed hydrosilylation of alkenes. Chin J Chem Eng 17:1038–104210.1016/S1004-9541(08)60314-6 ↗
2. Barth RF, Coderre A, Vicente M, Blue TE (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11:3987–400210.1158/1078-0432.CCR-05-0035 ↗
3. Bellott BJ, Noh W, Nuzzo RG, Girolami GS (2009) Nanoenergetic materials: boron nanoparticles from the pyrolysis of decaborane and their functionalisation. Chem Commun 22:3214–321510.1039/b902371b ↗
4. Bonora M, Cortia M, Borsaa F, Bortolussi S, Prottic N, Santoro D, Stella S, Altieri S, Zonta C, Clerici AM, Cansolino L, Ferrari C, Dionigi P, Porta A, Zanoni G, Vidari G (2001) 1H and 10B NMR and MRI investigation of boron- and gadolinium–boron compounds in boron neutron capture therapy. Appl Rad Isot 69:1702–170510.1016/j.apradiso.2011.02.021 ↗
5. Bradshaw KM, Hadley JR, Schweizer MP, Heilbrun MP, Davis WL and Glover GH (1996) First boron MRI of a human patient with a brain tumor. In: Cancer Neutron Capture Therapy, Y. Mishima, Ed., Springer, pp. 849–85310.1007/978-1-4757-9567-7_120 ↗
6. Brozek E, Zharov I (2009) Internal functionalization and surface modification of vinylsilsesquioxane nanoparticles. Chem Mater 21:1451–145610.1021/cm801894w ↗
7. Ceberg CP, Brun A, Kahl SB, Koo MS, Persson BR, Salford LG (1995) A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J Neurosurg 83:86–9210.3171/jns.1995.83.1.0086 ↗
8. Coletti C, Marrone A, Giorgi G, Sgamellotti A, Cerofonlini G, Re N (2006) Nonradical mechanisms for the uncatalyzed thermal functionalization of silicon surfaces by alkenes and alkynes: a density functional study. Langmuir 22:9949–995610.1021/la060013b ↗
9. Dávila-Ibáñez AB, López-Auintela A, Rivas J, Salgueirino V (2010) Optically active magnetic composites with responsive silica shells. J Phys Chem C 114:7743–775010.1021/jp100190j ↗
10. Diaz A, Stelzer K, Laramore G, Wiersema R (2002) Pharmacology studies of Na2 10 B10H10 (GB-10) in human tumor patients. In: Research and Development in Neutron Capture Therapy. Monduzzi Editore, Bologna, pp 993–999
11. Gao Z, Walton NI, Malugin A, Ghandehari H, Zharov I (2012) Preparation of dopamine-modified boron nanoparticles. J Mater Chem 22:877–88210.1039/C1JM12655E ↗
12. Grotheer EW (1979) Spectrophotometric determination of boric acid in boron powder with curcumin. Anal Chem 51:2402–240310.1021/ac50050a027 ↗
13. Hatanaka HA (1975) A revised boron-neutron capture therapy for malignant brain tumors. J Neurol 209:81–9410.1007/BF00314601 ↗
14. Hwang KC, Lai PD, Chiang CS, Wang PJ, Yuan CY (2010) Neutron capture nuclei-containing carbon nanoparticles for destruction of cancer cells. Biomaterials 31:8419–842510.1016/j.biomaterials.2010.07.057 ↗
15. Isaac MF, Khal SB (2003) Synthesis of ether- and carbon-linked polycarboranyl porphyrin dimers for cancer therapies. J Organomet Chem 680:232–24310.1016/S0022-328X(03)00391-7 ↗
16. Kabalka GW, Yao ML (2003) Synthesis of a potential boron neutron capture therapy agent: 1-aminocyclobutane-1-carboxylic acid bearing a butylboronic acid side chain. Synthesis 18:2890–289310.1055/s-2003-42479 ↗
17. Kabalka GW, Tang C, Bendel P (1997) The role of boron MRI in boron neutron capture therapy. J Neuro-Oncol 33:153–16110.1023/A:1005793903512 ↗
18. Kennedy DC, Duguay DR, Tay LL, Richeson DS, Pezacki JP (2009) SERS detection and boron delivery to cancer cells using carborane labelled nanoparticles. Chem Commun 44:6750–675210.1039/b916561d ↗
19. Marzik JV, Suplinskas RJ, Wilke RHT, Canfield PC, Finnemore DK, Rindfleisch M, Margolies J, Hannahs ST (2005) Plasma synthesized doped B powders for MgB2 superconductors. Physica C 423:83–8810.1016/j.physc.2005.04.005 ↗
20. Mishima Y, Ichihashi M, Tsui M, Hatta S, Ueda M, Honda C, Suzuki T (1989) Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 2:388–38910.1016/S0140-6736(89)90567-9 ↗
21. Mortensen MW, Sorensen PG, Bjorkdahl O, Jensen MR, Gundersen HJG, Bjornholm T (2006) Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy. Appl Radiat Isot 64:315–32410.1016/j.apradiso.2005.08.003 ↗
22. Mos RL (2014) Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT). Appl Rad Isot. 2014(88):2–1110.1016/j.apradiso.2013.11.109 ↗
23. Nakamura H, Miyajima Y, Takei T, Kasaoka S, Maruyama K (2004) Synthesis and vesicle formation of a nido-carborane cluster lipid for boron neutron capture therapy. Chem Commun 17:1910–191110.1039/B406141A ↗
24. Petersen MS, Petersen CC, Agger R, Sutmuller M, Jensen MR, Sørensen PG, Mortensen MW, Hansen T, Bjørnholm T, Gundersen HJ, Huiskamp R, Hokland M (2008) Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model. Anticancer Res 28:571–576
25. Pickering AL, Mitterbauer C, Browning ND, Kauzlarich SM, Power PP (2007) Room temperature synthesis of surface-functionalised boron nanoparticles. Chem Commun 6:580–58210.1039/b614363f ↗
26. Rohani P, Kim S, Swihart MT (2016) Boron nanoparticles for room-temperature hydrogen generation from water. Adv Energy Mater 6:150255010.1002/aenm.201502550 ↗
27. Shin WG, Calder S, Ugurlu O, Girshick SL (2011) Production and characterization of boron nanoparticles synthesized with a thermal plasma system. J Nanopart Res 13:7187–719110.1007/s11051-011-0633-3 ↗
28. Si PZ, Zhang M, You CY, Geng DY, Du JH, Zhao XG, Ma XL, Zhang ZD (2003) Amorphous boron nanoparticles and BN encapsulating boron nano-peanuts prepared by arc-decomposing diborane and nitriding. J Mater Sci 38:689–69210.1023/A:1021832209250 ↗
29. Soloway AH, Tjarks W, Barnum BA, Rong F-G, Barth RF, Codogni IM, Wilson JG (1998) The chemistry of neutron capture therapy. Chem Rev 98:1515–156210.1021/cr941195u ↗
30. Stӧber W, Fink A, Bohn E (1968) Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 26:62–6910.1016/0021-9797(68)90272-5 ↗
31. Thangavel S, Dhavile SM, Chaurasia SC (2004) Spectrophotometric determination of boron in complex matrices by isothermal distillation of borate ester into curcumin. Anal Chim Acta 502:265–27010.1016/j.aca.2003.10.003 ↗
32. Tietze LF, Griesbach U, Bothe U, Nakamura H, Yamamoto Y (2002) Novel carboranes with a DNA binding unit for the treatment of cancer by boron neutron capture therapy. Chembiochem 3:219–22510.1002/1439-7633(20020301)3:2/3<219::AID-CBIC219>3.0.CO;2-# ↗
33. Van Devener B, Perez JPL, Anderson SL (2009a) Air-stable, unoxidized, hydrocarbon-dispersible boron nanoparticles. J Mater Res 24:3462–346410.1557/jmr.2009.0412 ↗
34. Van Devener B, Perez JPL, Jankovich J, Anderson SL (2009b) Oxide-free, catalyst-coated, fuel-soluble, air-stable boron nanopowder as combined combustion catalyst and high energy density fuel. Energy Fuel 23:6111–612010.1021/ef900765h ↗
35. Valliant JF, Guenther KJ, King AS, Morel R, Schaffer P, Sogbein OO, Stephenson KA (2002) The medicinal chemistry of carboranes. Coord Chem Rev 232:173–23010.1016/S0010-8545(02)00087-5 ↗
36. Woodhouse SL, Rendina LM (2001) Synthesis and DNA-binding properties of dinuclear platinum (II)–amine complexes of 1,7-dicarba-closo-dodecaborane(12). Chem Commun 23:2464–246510.1039/b108081d ↗
37. Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ (2008) Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Clinical Cancer Res 14:883–89110.1158/1078-0432.CCR-07-1968 ↗
38. Yao JZ, Chen YY, Tian BS (1997) Synthesis of polysiloxane-supported ferrocenyl selenoether platinum complexes and their catalytic behavior in the hydrosilylation of olefins with triethoxysilane. J Organomet Chem 534:51–5610.1016/S0022-328X(96)06873-8 ↗